Maze CEO Jason V. Coloma sells shares worth about $593K
Maze Therapeutics CEO Jason V. Coloma reported sales of common stock to satisfy tax withholding on vested restricted stock units, executed at weighted average prices of $26.376, $27.1211 and $26.0133 per share.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.